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Abstract
Background: Intrinsic apoptosis of neuronal somas is one aspect of neurodegenerative diseases
that can be influenced by genetic background. Genes that affect this process may act as
susceptibility alleles that contribute to the complex genetic nature of these diseases. Retinal
ganglion cell death is a defining feature of the chronic and genetically complex neurodegenerative
disease glaucoma. Previous studies using an optic nerve crush procedure in inbred mice, showed
that ganglion cell resistance to crush was affected by the Mendelian-dominant inheritance of 1–2
predicted loci. To assess this further, we bred and phenotyped a large population of F2 mice
derived from a resistant inbred strain (DBA/2J) and a susceptible strain (BALB/cByJ).
Results: Genome wide mapping of the F2 mice using microsatellite markers, detected a single
highly significant quantitative trait locus in a 25 cM (58 Mb) interval on chromosome 5 (Chr5.loc34-
59 cM). No interacting loci were detected at the resolution of this screen. We have designated this
locus as Retinal ganglion cell susceptible 1, Rgcs1. In silico analysis of this region revealed the
presence of 578 genes or expressed sequence tags, 4 of which are highly expressed in the ganglion
cell layer of the mammalian retina, and 2 of which are suspected susceptibility alleles in chronic
neurodegenerative diseases. In addition, 25 genes contain 36 known single nucleotide
polymorphisms that create nonsynonymous amino acid changes between the two parental strains.
Collectively, this analysis has identified 7 potential candidate genes that may affect ganglion cell
death.
Conclusion: The process of ganglion cell death is likely one of the many facets of glaucoma
susceptibility. A novel dominant locus has been identified that affects sensitivity of ganglion cells to
optic nerve crush. The allele responsible for this sensitivity may also be a susceptibility allele for
glaucoma.
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Background
Glaucoma is a blinding disease characterized by the pro-
gressive death of retinal ganglion cells. The principal risk
factor for glaucoma is elevated intraocular pressure (IOP)
[1-3]. Biomechanical engineering studies suggest that
IOP-related stress is focused on ganglion cell axons exiting
the eye through the lamina cribrosa [4,5]. Current models
suggest that optic nerve glia are adversely affected and that
this leads first to destruction of the ganglion cell axon, and
secondarily, to the apoptotic death of the ganglion cell
soma (reviewed by [6,7]).
Glaucoma is a complex genetic disease [8]. After elevated
IOP, family history is the next most important risk factor
[9,10]. While many important studies have revealed a
great deal about the genetics of this disease, the majority
of these have been restricted to relatively rare forms that
exhibit some form of Mendelian inheritance and for
which there are large pedigrees that contribute both phe-
notypic and genotypic information. For most forms of
glaucoma, there is limited understanding of the genetics
underlying disease susceptibility. One approach to identi-
fying glaucoma susceptibility alleles is to first identify can-
didate genes using mouse genetics. Specifically, we
hypothesized that the process of retinal ganglion cell
death may be affected by genetic background. Several
studies in mice have documented quantitative trait loci
(QTL) that associate with neuronal degeneration. These
include loci that affect neuronal susceptibility in the sub-
stantia nigra to the Parkinsonian drug MPTP [11,12] or
sensitivity to kainic acid in the hippocampus [13]. Addi-
tionally, reduced Bax expression in ganglion cells created
in gene dosage experiments, completely abrogates soma
death in both acute optic nerve lesion and chronic glau-
coma models in mice [14,15].
In an effort to identify alleles affecting ganglion cell death,
we screened inbred mice to examine if genetic background
influenced cell loss after optic nerve crush. This lesion
stimulates several of the same molecular pathways active
in dying ganglion cells in glaucoma [15-19]. A screen of
15 different lines showed that genetic background did
affect the loss of these cells. Reciprocal backcross breeding
experiments using the most resistant (DBA/2J) and sus-
ceptible lines (BALB/cByJ) indicated that the resistant
phenotype was attributable to 1–2 dominant loci [20]. In
this report, we have extended this observation to show the
results of a genome wide screen of a large F2 mapping
population generated from these two parental inbred
lines. This study reveals a single significant dominant QTL
on chromosome 5 that associates with the cell death phe-
notype. We have designated this locus as Retinal ganglion
cell susceptible 1 (Rgcs1).
Results
A single dominant QTL affecting retinal ganglion cell 
death is located on chromosome 5
A population of 196 F2 mice underwent optic nerve crush
and cell loss phenotyping. The distribution of phenotypes
in this population (Fig. 1) matched well with a smaller
population of F2 mice examined previously [20], indicat-
ing that the phenotype was consistently inherited. For
genome wide mapping, we selected mice from the F2 pop-
ulation that had 54% or less cells remaining (the most
susceptible mice) and 64% or more cells remaining (the
most resistant mice). These animals are indicated by the
filled bars in the phenotype frequency histograph of the
F2 population (Fig. 1).
Quantitative trait linkage analysis using 65 microsatellite
markers, with and without sex as a covariate, showed a
single significant peak on chromosome 5 between mark-
ers D5Mit254 (34 cM) and D5Mit338 (59 cM) (Fig. 2).
The maximum LOD score predicted by interval analysis
was 5.825 at Chr5.loc38 (inset Fig. 2), which was the only
locus that exceeded the significance level of P = 0.05 (P =
0.0011 for the peak). The next highest LOD score in the
analysis of all the samples modeled without interactive
covariates was 3.045 for D6Mit83 on chromosome 6
(Chr6.loc3.5). It is notable that evaluation of larger num-
Frequency histograph of phenotype for the 196 mice in the  F2 mapping population Figure 1
Frequency histograph of phenotype for the 196 mice 
in the F2 mapping population. The loss of cells in each 
experimental retina was quantified as a percentage of cells 
present in the control retina of each mouse. Filled bars indi-
cate mice in each tail of the population distribution that were 
selected for genotyping. Susceptible mice exhibited ≤ 54% 
cells remaining, while resistant mice exhibited ≤ 64% cells 
remaining.BMC Neuroscience 2008, 9:74 http://www.biomedcentral.com/1471-2202/9/74
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bers of animals from the F2 population may have not only
increased the significance of the locus on chromosome 5,
but also increased the LOD score at Chr6.loc3.5 to above
the threshold value. The QTL dataset was also analyzed for
interacting loci, again including sex as a covariate. No sig-
nificant associations were detected at the resolution of
this genome-wide screen, thus a single locus on chromo-
some 5 accounts for 11.61% of the phenotypic variance of
this trait. This locus has been designated as Retinal gan-
glion cell susceptible 1 (Rgcs1). For subsequent analyses,
we have conservatively defined this locus by the nearest
markers used for mapping. This 58 Mb region includes an
approximation of the 95% confidence interval as sug-
gested by a 1.5 LOD drop from the peak [21].
We also examined the inheritance pattern of phenotype as
a function of marker D5Mit254, which lies closest to the
region with the statistical maximum LOD score (Fig. 3).
Mice inheriting 2 BALB/c alleles have significantly fewer
cells remaining than mice inheriting 1 or 2 DBA/2J alleles
(t-test, P = 4.4 × 10-7). Conversely, mice heterozygous for
the DBA/2J locus exhibited a statistically equivalent phe-
notype to mice homozygous at this locus (P = 0.169).
Together, these data are supportive of our original obser-
vation of the Mendelian-dominant nature of the Rgcs1
locus obtained from reciprocal breeding experiments
[20].
Identification of candidate genes in the Rgcs1 locus
Genomic sequence information, available for multiple
different strains of mice (please see Availability & require-
ments for more information), was examined to identify
candidate genes. The region of Chr5.loc34-59 was found
to be relatively gene poor, with a total of 578 known genes
A genome scan showing a significant QTL on chromosome 5 that maps to the cell death phenotype Figure 2
A genome scan showing a significant QTL on chromosome 5 that maps to the cell death phenotype. The micro-
satellite mapping data was analyzed individually for male and female mice, and for all the mice with and without sex as an inter-
active covariate. The observed LOD score was compared to 10000 LOD scores with permuted phenotypes [61], yielding a 5% 
significance threshold of 4.15. The inset shows a detail of the LOD scores for all 3 markers used for chromosome 5 (Chr5). 
The region of interest maps between 34 and 59 cM with the predicted maximum LOD score (5.825) at 38 cM. This locus has 
been designated as Retinal ganglion cell susceptible 1 (Rgcs1).BMC Neuroscience 2008, 9:74 http://www.biomedcentral.com/1471-2202/9/74
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and/or expressed sequence tags (ESTs) identified. Based
on existing sequence data, we used in silico analysis to find
single nucleotide polymorphisms (SNPs) creating non-
synonymous amino acid changes between the DBA/2J
and BALB/cByJ strains. This search identified 36 amino
acid changes in 25 genes (Table 1). Of these changes, 12
were conservative changes and 24 were non-conservative,
including 2 that change a hydrophobic amino acid in
DBA/2J mice to a proline in BALB/c mice (genes Tlr1 and
Ugt2a3).
We also examined the list of polymorphisms for similari-
ties to other mouse strains with cell death phenotypes
similar to either the resistant or susceptible strains. Of the
25 genes identified, 2 genes clearly exhibited strain clus-
tering of a polymorphism, while 7 other genes (totaling 8
SNPs) showed possible clustering. The basis for this latter
definition was that only partial sequence data was availa-
ble for reference strains or intermediate strains (see Meth-
ods). Of these 9 potential genes, 7 exhibited non-
conservative amino acid changes.
A second layer of analysis was then conducted to identify
genes in this region that were highly expressed or enriched
in cells of the ganglion cell layer, including ganglion cells
themselves, by screening available microarray data. Four
genes in the Rgcs1  region were found as being either
highly enriched, or highly expressed, in the ganglion cell
layer and optic nerve head, including Pcdh7,  Uchl1,
Sparcl1, and Cplx1 (Table 2). Of these 4, Sparcl1 appeared
on both lists of SNP-containing genes and genes expressed
in the ganglion cell layer. All 4 of these candidate genes
showed a decrease in expression level in arrays of axot-
omized or glaucomatous rat retinas [22].
Finally, a search of the 578 genes was made to identify
candidates that had already been identified as susceptibil-
ity alleles for other neurodegenerative diseases. This
search yielded 2 genes, HspB8 and Uchl1. The latter gene
was also identified in the search of genes present in the
retinal ganglion cell layer. Collectively, using the criteria
of expression in the retina, ganglion cell layer, or other
CNS neurons; and/or the presence of strain-specific non-
conserved amino acid changes; and/or the involvement of
genes in neurodegeneration, we identified 7 genes as pos-
sible candidate genes that could affect retinal ganglion cell
death after lesion to the optic nerve (Table 2).
Discussion
In an attempt to determine if genetic background influ-
ences the process of retinal ganglion cell death after dam-
age to the optic nerve, we conducted a screen of inbred
mice for susceptibility to a crush lesion of the optic nerve.
Breeding studies conducted as part of this series of exper-
iments, suggested that resistance to crush was inherited in
a dominant fashion involving relatively few alleles [20].
This finding was expanded to conduct genome wide map-
ping of a population of F2 mice generated from resistant
(DBA/2J) and susceptible (BALB/cByJ) parental strains.
Mapping identified a single QTL on chromosome 5, span-
ning a region of 25 cM delineated by markers D5Mit254
and D5Mit338, which significantly associated with the
dominant inheritance of resistance to the crush proce-
dure. In silico analysis of the 578 known genes and ESTs in
this region identified 7 candidate genes that can be stud-
ied further, in concert with more detailed mapping studies
to narrow the region of interest.
Rgcs1 represents a novel QTL relative to other loci that
have been mapped in association with neurodegenera-
Rgcs1 is a Mendelian-dominant locus affecting ganglion cell  susceptibility to optic nerve crush Figure 3
Rgcs1 is a Mendelian-dominant locus affecting gan-
glion cell susceptibility to optic nerve crush. The mean 
(± s.d.) cells remaining for F2 mice were plotted as a function 
of inheritance of the D5Mit245 polymorphic marker. This 
marker is closest to the predicted location of chromosome 5 
with the highest LOD score. Mice homozygous or hetero-
zygous for the DBA/2J allele (D) have statistically equivalent 
phenotypes (t-test, P = 0.169), while mice that have inherited 
2 BALB/c alleles (C) have significantly fewer cells remaining 
compared to F2 mice carrying a D allele (P = 4.4 × 10-7). 
These C/C mice exhibit a phenotype that is similar to the 
susceptible phenotype of the BALB/c parental strain.BMC Neuroscience 2008, 9:74 http://www.biomedcentral.com/1471-2202/9/74
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tion. These include QTLs on chromosomes 1 [11], 13, and
15 [12], that associate with MPTP toxicity and a QTL on
chromosome 18 that affects susceptibility to kainic acid
[13]. Interestingly, Rgcs1  lies within a QTL that maps
between 26 and 61 cM on chromosome 5 that affects the
thresholds for electroshock induced seizures in mice [23].
The causative gene is likely not linked to Rgcs1, however,
since DBA/2J mice exhibit greater susceptibility to electro-
shock. Lastly, inbred strains of mice exhibit a bimodal dis-
tribution of retinal ganglion cell number in adult animals
that has been genetically mapped to a QTL on chromo-
some 1 [24]. Since ganglion cell number in adults is influ-
enced by the process of cell death during development,
this region has been examined for its effects on both gan-
glion cell specification and production, and on pro-
grammed cell death (PCD) [25]. Examinations of cell
number before the onset of PCD, however, showed that
strains with large numbers of ganglion cells as adults gen-
erally had equally large numbers of immature cells, and
vice versa, suggesting that the process of cell death was not
affected by this QTL.
Summary of candidate genes and their relevance to retinal 
ganglion cell death and neurodegeneration
The 7 candidate genes (Table 2) are distributed in two
main clusters, each at either end of the 25 cM interval cur-
Table 1: Summary of SNP polymorphisms between DBA/2J and BALB/c mice, affecting coding regions of genes and ESTs in the Rgcs1 
locus
Gene Name DBA/2J AA BALB/c AA Position Conserved* Strain Cluster†
Tlr1 C Q T R 667 No Possible
Tlr1 G L A P 246 No Possible
Tlr1 GLAS 1 1 1 N o N o
Tlr6 TVCI 6 8 1 Y e s Y e s
9130005N14Rik GTAA 4 9 8 N o N o
Recc1 CNT S 5 8 8 Y e s N o
Klb TTCM5 1 1 N o N o
B3bp ASGG1 6 2 6 N o N o
EG545758 ASGL1 4 1 N o N o
Npal1 G H A R 178/197 Yes No
BC031901 CGTE 4 3 2 N o N o
BC031901 ARCL 3 9 8 N o N o
EG627807 TSC N 4 4 Y e s N o
Rest AGGS 5 5 5 N o N o
EG384187 CEGQ 6 7 N o N o
EG384187 GVTG 9 1 Y e s N o
EG384187 TKAN1 4 4 N o N o
EG384187 GVTG1 6 0 Y e s N o
EG384187 TTCI 1 6 4 N o N o
Ugt2b1 GLAF 4 2 5 N o N o
Ugt2a3 T T G P 508 No Possible
Ugt2a2 GATE 5 0 0 N o N / A
Ugt2a2 CRGG4 6 7 N o Y e s
C230008H04Rik CKTE 3 7 N o N o
Slc10a6 CTTA 2 N o N o
Klhl8 TRCQ 1 8 N o N o
Sparcl1 G R A Q 384 No Possible
Zfp326 G G A D 493 No Possible
Zfp644 CNT S 2 1 0 Y e s N o
4921521K07Rik A I G V 102 Yes Possible
4921521K07Rik TFAY2 8 0 Y e s N o
A830010M20Rik G D A N 382/630 No No
A830010M20Rik G S A N 762/1010 Yes Possible
AW060207 G D A G 279 No Possible
AW060207 GHCQ3 5 5 Y e s N o
Pigg GVA I 1 3 2 Y e s N o
*Conservative vs Non-conservative amino acids (AA) were assigned based on differences in charge and hydrophobicity. †Strain clustering refers to 
data showing the same SNP in at least one reference mouse strain with a similar quantitative phenotype. A score of No indicates a DBA/2J or 
BALB/c polymorphism in at least one conflicting reference strain. A score of Possible indicates polymorphisms that fit trend for intermediate 
strains, but for which there is limited data for reference strains, or where there is data only for one set of reference strains. Reference strains 
examined were 129X1/SVJ and C57Bl/6J for DBA/2J mice, and NOD/LtJ and C3H/HeJ for BALB/cByJ mice. Intermediate strains were A/J and NZB/
BINJ [20].BMC Neuroscience 2008, 9:74 http://www.biomedcentral.com/1471-2202/9/74
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rently defining the Rgcs1 locus (Fig. 4). In response to a
lesion of the optic nerve, each candidate gene could real-
istically play a role in the process of retinal ganglion cell
death. However, this does not preclude the possibility that
a different gene (or genes) in this region may be responsi-
ble for the QTL. Also, it is important to note that our eval-
uation of candidate genes did not address the possibility
that the causative gene could be an expression QTL, where
polymorphisms in the promoter region could affect
expression levels. Alternatively, non-coding polymor-
phisms could also create alternative splice variants in
some genes that can affect protein structure or transcript
stability. Lastly, our in silico analysis did not address the
possibilities of differences in non-coding RNAs (such as
microRNAs) that may exist between the two strains, but
which could also affect gene expression and cellular proc-
esses. Still, the filters we used for selection criteria were
biased towards assessing relevant features that could dra-
matically account for a QTL between the two strains. A
summary of each gene follows:
Pcdh7 (Protocadherin 7)
Pcdh7 is one of a member of a family of cadherin like mol-
ecules that play a specialized role in cell-cell interactions
within the central nervous system [26,27]. The functional
role of Pcdh7 is not well understood, but splice variants
have been implicated in altering cell adhesion properties.
This may affect both ganglion cell and retinal glial cell
gene expression profiles by modifying cellular interac-
tions with the extracellular matrix.
Tlr1 and Tlr6 (Toll-like Receptors 1 and 6)
There are 9 known Tlr genes in mice and all of them are
expressed by microglia in the CNS [28]. In addition, indi-
rect evidence suggests that astrocytes also express at least
some Tlr genes. They function by allowing microglia to
recognize and respond to a wide variety of pathogens and
injury-resulting antigens, thus implicating these cells in
both the innate and adaptive immune response of the
CNS. It is not known if TLRs play a role in the activation
response of microglia after optic nerve injury, but through
TLR activation [28], these cells have been shown to
express MHC class II proteins and act as antigen present-
ing cells in models of demyelinating diseases in mice [29].
Genetically controlled selective autoimmunity responses
in mice can modulate the severity of retinal damage in
acute (crush) and chronic (experimental glaucoma) mod-
els of optic nerve lesion [30-32]. This, along with the
growing evidence that neuroinflammation can affect both
neuronal survival and death [33], makes these genes
attractive candidates for the cell death phenotype.
Uchl1 (ubiquitin C-terminal hydrolase-1)
UCHL-1 plays an integral role in the ubiquitin proteo-
some pathway. It hydrolyses small ubiquitin C-terminal
adducts and may have a role in regulating the degradation
Table 2: Summary of all candidate genes.
Gene Name Chromosome Position 
(starting bp)
Retinal Expression Coding Region SNPc Strain Associationd Role in Neurodegeneration
Pcdh7 58006337 GCL enricheda,b No N/A Unknown
Tlr1 65203969 Confirmedb Yes Possible Immune Modulatione
Tlr6 65232241 Confirmedb Yes Yes Immune Modulatione
Uchl1 66955376 GCL enricheda,b No N/A eQTL Susceptibility Allelef
Sparcl1 104319413 GCL enricheda,b Yes Possible Possible Glial Activationg
Cplx1 108760431 GCL enricheda,b No N/A 2° Degenerationh
Hspb8 116669490 Confirmedb No N/A Susceptibility Allelei
The chromosomal position of each gene is shown, along with a short summary of how each gene scored in the different criteria for identifying 
candidate genes.
aIdentified from microarray expression profiles.
bThe expression of each candidate gene was confirmed in the mouse retina using reverse transcriptase-PCR amplification of a portion of its cDNA 
(data not shown).
cSingle nucleotide polymorphism (SNP) analysis was conducted in silico using sequence information available on the MGI data base. SNPs that 
resulted in coding region changes between DBA/2J and BALB/cByJ mice were examined.
dCoding region SNPs between DBA/2J and BALB/cByJ mice were compared to reference strains if sequence data were available. Reference strains 
included 129X1/SVJ and C57Bl/6J as resistant strains comparable to DBA/2J mice, and NOD/LtJ and C3H/HeJ as susceptible strains comparable to 
BALB/cByJ mice. Intermediate strains included A/J (as a likely resistant strain) and NZB/BINJ (as a likely susceptible strain). For genes showing a SNP 
difference, if the same SNP was noted in the reference strains it was scored as showing a positive strain association. A possible strain association 
was recorded if sequence data was limited to only a resistant or susceptible reference strain, or the intermediate strains showed the predicted 
strain association, but there was not data available for the reference strains. If no SNP was noted, the strain association analysis was not applicable 
(N/A).
e[31,33].
f [34-36].
g[37].
h[40].
i[45]BMC Neuroscience 2008, 9:74 http://www.biomedcentral.com/1471-2202/9/74
Page 7 of 11
(page number not for citation purposes)
of free ubiquitin monomers. Studies have documented 2
separate polymorphisms in human UCHL-1 that associate
with either increased or decreased susceptibility to Parkin-
son's disease, although the concordance of these studies is
variable. The pathology of UCHL-1 is most likely linked to
changes in activity or expression levels. The putative Par-
kinson's disease causing allele in UCHL-1 results in a 50%
decrease in enzyme catalytic activity [34]. Similarly,
reduced overall gene expression of UCHL-1 is associated
with the formation of Lewy bodies in patients with
dementia [35] and the development of gracile axonal dys-
trophy and intraneuronal inclusions in mice [36]. These
observations suggest that Uchl1 expression levels may play
a factor in neuronal susceptibility. In addition to its sus-
pected role as a susceptibitily allele for chronic neurode-
generation,  Uchl1  expression is highly enriched in the
ganglion cell layer. Although not polymorphic, quantita-
tive differences in expression, if any, could account for the
different cell death phenotypes between strains.
Sparcl1 (secreted protein acidic and rich in cysteine-like 1, Hevin, 
SC1)
The Sparcl1 gene product is a secreted protein that acts as
a de-adhesive molecule [37]. It is expressed and secreted
by neurons and glia presumably to allow cells to release
contact from the extracellular matrix and begin to migrate.
Increased Sparcl1 expression is associated with regions of
neuronal injury, possibly playing a role in the glial activa-
tion response. Sparcl1 is the only gene we have identified
that is enriched in the ganglion cell layer and has a poly-
morphism that results in a non-conservative amino acid
change (an R to Q at position 384, near the junction of the
acidic N-terminal domain and the Follistatin like domain
[38]).
Cplx1 (Complexin I)
Complexin I is involved in synaptic vesicle trafficking in
neurons. Complexins associate with the vesicle SNARE
complex at some point during or just after the process of
Ca2+-dependent fast synchronous transmitter release [39].
Both Complexin I and II have been implicated in human
neurodegenerative disorders, but this involvement is not
clear. The increased expression of both molecules has
been documented after traumatic brain injury, suggesting
involvement in the glutamate release response of dam-
aged neurons [40]. Mice mutant for Cplx1 develop severe
ataxia and behavioral disorders [41]. This gene was prin-
cipally identified because it is highly expressed in the gan-
glion cell layer. However, its potential role in excitotoxic
damage may affect ganglion cell death in both optic nerve
crush and glaucoma insults, where secondary degenera-
tion mediated by glutamate-toxicity has been implicated
in both models of damage [42,43].
HspB8 (22 kDa heat shock protein)
HSPB8 is a member of the small heat shock protein
(sHSP) family of molecular chaperones [44]. Mutations in
the α-crystallin domain of HSPB8 in humans leads to dis-
tal hereditary motor neuropathy [45], a disease character-
ized by the degenerative loss of motor neurons. There
have been reports that several members of the sHSP gene
family are differentially regulated in animal models of
glaucoma [46], although no study has focused specifically
on HspB8.
Rgcs1 and retinal ganglion cell death in glaucoma
Although Rgcs1 affects ganglion cell death after acute optic
nerve crush, the role of the causative gene in this region as
a susceptibility allele in glaucoma is not yet resolved.
Acute nerve lesion and elevated IOP appear to activate a
similar intrisinc apoptotic program, associated with Bax-
dependent mitochondrial changes [14,15,47] and the
activation of the caspase cascade [17,48-51]. Additionally,
genome wide microarray studies conducted on early,
intermediate, and late retinal gene expression changes
Synteny map of Rgcs1 between mouse and human genomes Figure 4
Synteny map of Rgcs1 between mouse and human 
genomes. The region of Rgcs1 on mouse chromosome 5 is 
shown along with the relative positions of the 7 candidate 
genes. These genes form 2 distinct clusters near the ends of 
the locus. The majority of the Rgcs1 locus is represented on 
human chromosome 4, between 4p15 and 4q21, although a 
small segment containing the human HSPB8 gene is located 
on chromosome 12 at 12q24.BMC Neuroscience 2008, 9:74 http://www.biomedcentral.com/1471-2202/9/74
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from both axotomy injured rat eyes and eyes with experi-
mental glaucoma showed significant overlap in the genes
that were differentially expressed in both conditions [22].
These changes included early injury response genes (i.e.,
cJun and Junb), and stress response genes (i.e., Hsp27 and
Ceruloplasmin). Additionally, ganglion cell specific
genes, such as Thy1 and Sncg, were similarly down-regu-
lated. There were specific differences in the pattern of dif-
ferentially regulated genes, however, that may reflect
different mechanisms of ganglion cell pathology between
the two modalities of injury. Most prevalent was the up-
regulation of genes involved in neuroinflammation, such
as components of the complement cascade, in the experi-
mental glaucoma retinas. Thus, neurinflammation may
play a greater role in ganglion cell death during a chronic
neurodegenerative process, than in an acute paradigm.
Interestingly, DBA/2J mice, which carry the resistant Rgcs1
genotype, exhibit a glaucoma phenotype characterized by
progressive ganglion cell loss [52-54]. Since the dominant
Rgcs1 allele does not completely abrogate cell death, we
would not expect this strain to be completely resistant to
glaucoma. Instead, we speculate that DBA/2J mice would
exhibit a more severe phenotype if they carried the BALB/
cByJ allele and experiments to create such a congenic
strain are underway.
The role of Rgcs1 in glaucoma may also be inferred by
comparison of mouse locus with the syntenic region in
the human genome. The interval of interest on mouse
Chr5 is principally represented on human Chr4 between
4p15 and 4q21 and a short segment of human Chr12,
centered at 12q24 (Fig. 4). To date, no linkage studies
examining forms of glaucoma with Mendelian inherit-
ance patterns have identified genes or loci in these regions
[8,55]. This is not surprising since these studies have
depended on relatively rare forms of glaucoma, while
most forms of primary open angle glaucoma exhibit
much higher levels of genetic complexity [8]. We predict
that the retinal ganglion cell susceptibility allele, if it does
influence cell loss in glaucoma, would be just one of sev-
eral genes that contribute to a more complex genetic dis-
order.
Interestingly, markers on human Chr4 that map near the
region of interest (Fig. 4), showed promising results in a
genome-wide screen of DNA from 113 sib-pairs affected
with primary open angle glaucoma [56]. In particular,
marker D4S2397 (4p15.2) was initially positive in 3 inde-
pendent analyses, including model-dependent LOD
scores and sib-pair maximum LOD scores. Marker
D4S400 (4q21.22) was positive in 2 of 3 analyses. These
markers on Chr4, however, failed to continue to show
positive results when this analysis was expanded to
include a second cohort of affected sib-pairs. Given the
small size of this sib-pair screen, it may not yet be possible
to interpret the relative importance of this region in
human glaucoma, but it is encouraging that it has shown
some promising results in linkage studies.
Conclusion
Susceptibility of retinal ganglion cell death to a crush
lesion of the optic nerve is influenced by genetic back-
ground. Linkage analysis of a large mapping population
has helped resolve this genetic contribution to a locus on
chromosome 5 between 34–59 cM. In silico examination
of this region has identified 7 potential candidate genes
that may account for the difference in ganglion cell death
phenotype exhibited by the DBA/2J and BALB/cByJ
strains. Evaluation of the effect of the BALB/cByJ locus in
the DBA/2J mouse model of glaucoma will help confirm
this gene/region as being a susceptibility allele for glau-
coma as well as for acute optic nerve crush.
Methods
Animals
All mice were handled in accordance with the Association
for Research in Vision and Ophthalmology statement for
the use of animals for research and experimental proto-
cols were approved by the Animal Care and Use Commit-
tee of the University of Wisconsin. DBA/2J and BALB/cByJ
parental mice were purchased from the Jackson Labora-
tory (Bar Harbor, ME). These mice were bred to generate
F1 offspring, which were then interbred by reciprocal
crosses to generate F2 mice for analysis. Mice were housed
in microisolator cages and kept on a 12 hr light/dark cycle.
They were maintained on a 4% fat diet (8604 M/R, Har-
land Teklad, Madison, WI).
Phenotyping and genotyping
To estimate the size of the mapping population required
to successfully identify loci associated with the cell death
phenotype, we conducted power calculations using phe-
notype and inheritance information acquired from earlier
studies of smaller populations of N2 backcrossed and F2
mice [20]. The mouse genome size was approximated as
20 chromosomes of 100 cM in length and the proposed
mapping interval was 20 cM. Since parental strain data
provided no information regarding the dominance effect
(δ), power calculations were made using the assumptions
that δ = α (where α = the additive effect of phenotype) or
δ = 0 (δ had no additive effect). Heritability of the locus of
interest (h2) was then calculated using the information
provided from our preliminary data sets (h2 = 32.7% for δ
= α, and 24.5% for δ = 0). Power calculations were per-
formed using the formula and parameters described pre-
viously [57]. Within the heritability range of our existing
population studies, these calculations suggested that a
population of 100 F2 mice would have sufficient power to
detect a single locus that associates with phenotype usingBMC Neuroscience 2008, 9:74 http://www.biomedcentral.com/1471-2202/9/74
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this mapping strategy. To further increase the likelihood
of detecting a QTL, we also biased the genotyping of the
population to the most extreme ends of the distribution
[58]. Consequently, 196 mice were phenotyped and from
this, 60 were selected as the most resistant and 49 were
selected as the most susceptible.
Consistent with our previous studies on other inbred
mice, we aged the F2 pups to 8 weeks, at which time they
underwent the optic nerve crush protocol. Optic nerve
crush was performed on the left eye of each mouse using
an intraorbital approach [20,59]. Previously, mice were
euthanized 2 weeks after this procedure. However, time
course analysis of cell loss over a 3 week period showed
the same difference in cell loss between the 2 parental
strains at both 2 and 3 weeks (data not shown). Since 3
weeks represented a more end-stage point of the cell death
process, we opted to analyze the mapping population at
this time after crush. Retinas were processed for quantifi-
cation as described previously [20]. Approximately 10%
of the entire population of neurons in the ganglion cell
layer was sampled from each retina. Cell loss for each
mouse was recorded as the percentage of cells remaining
in the experimental retina relative to the fellow control
retina. Previous studies have verified that DBA/2J and
BALB/cByJ mice have an equal percentage of ganglion
cells making up the neuronal population of the ganglion
cell layer [20], and we have made the assumption that this
relationship holds true to F2 mice generated from these
parental strains.
More than 100 informative microsatellite markers
between DBA/2J and BALB/cByJ mice were identified
from the Mouse Genome Informatics (MGI) website of
the Jackson Laboratory (please see Availability & require-
ments for more information). These markers were spaced
roughly 20 cM apart and exhibited at least a 5 bp differ-
ence between the strains. Primer pairs for each marker
were individually tested on genomic DNA isolated from
spleens of parental mice. PCR conditions were empirically
optimized for each primer pair, but typically primers were
annealed at 55°C and reactions were run for a minimum
of 40 cycles. Bands were evaluated on standard 1–3% aga-
rose gels stained with ethidium bromide. After empirical
testing, we selected 65 markers for genotyping. This
included a minimum of 3 markers per chromosome and
an approximate genome-wide scan radius of 15 cM with
each marker separated by approximately 30 cM. At this
distance, the proximal ends of chromosomes 1, 9, and 13,
and the distal ends of chromosomes 3, 5, 11, and 19 were
not fully covered by the markers used. Genotyping was
performed using spleen DNA isolated from 60 resistant
and 49 susceptible mice. Data were scored by an observer
(JAD) masked to the phenotype and entered into an Excel
(Microsoft, Redmond, WA) spreadsheet. Discrepancies in
genotype reading were resolved by regenotyping.
Data analysis
The resulting data set (of phenotype and genotype for all
109 mice) was analyzed using the R/qtl statistical software
package (please see Availability & requirements for more
information) [60]. Simple interval mapping adjusting for
possible sex by genotype interaction was performed across
the genome with 2cM steps. A 5% permutation threshold
[61] was estimated as 4.15 based on 10000 sets of per-
muted genotypes.
In silico analysis to identify candidate genes
Chromosomal regions of interest identified from interval
mapping analysis were analyzed further for potential can-
didate genes using an in silico approach. All known genes
and ESTs present in the region were identified from
mouse genomic sequence data present in the MGI data-
base (please see Availability & requirements for more
information). This database also included supplementary
information on localization and known function of gene
products. Candidate genes were identified using three lev-
els of criteria.
Criterion 1: SNP analysis
Because there is sequence data available for multiple
strains, it was possible to data mine for SNPs between
DBA/2J and BALB/cByJ mice in the region of interest,
including SNPs that create non-synonymous amino acid
changes. Informative SNPs could also be examined for
strain clustering, when possible, using data on the cell
death phenotype we had characterized for other mouse
strains [20]. Reference strains included 129X1/SvJ and
C57BL/6J as resistant strains, and C3H/HeJ and NOD/LtJ
as susceptible strains. Intermediate strains included A/J
(likely resistant) and NZB/BINJ (likely susceptible). SNPs
that were negative for strain clustering (i.e., DBA/2J and
NOD/LtJ mice sharing the same polymorphism, etc) were
excluded from further consideration.
Criterion 2: microarray expression data
The list of genes identified in a region of interest was also
compared to gene expression profiles reported for mam-
malian retinal ganglion cells, the ganglion cell layer, or
whole retina in response to glaucoma or optic nerve
lesion. These profiles included: (i) laser captured human
ganglion cell layer [62], (ii) primary cultures of purified
rat retinal ganglion cells [63,64], (iii) non-human primate
retina with experimental glaucoma [65], (iv) rat retina
with experimental glaucoma or after axotomy [22], (v) rat
optic nerve heads with experimental glaucoma [66], (vi)
and aging retinas from DBA/2J mice [46].BMC Neuroscience 2008, 9:74 http://www.biomedcentral.com/1471-2202/9/74
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Criterion 3: Functional analysis
Finally, genes in this region were screened for functional
information that indicated their expression pattern and
linked them as susceptibility alleles in other neurodegen-
erative diseases. Some genes for which there was no
expression data confirming expression in the CNS, or any
known functional data, were not considered for selection
in this analysis even though they may have met other cri-
teria.
Availability & requirements
Genomic sequence information: http://www.informat
ics.jax.org/javawi2/servlet/WIFetch?page=snpQF
Mouse Genome Informatics (MGI) website of the Jackson
Laboratory: http://www.informatics.jax.org
R/qtl statistical software package: http://www.rqtl.org
MGI database: http://www.informatics.jax.org
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